about
TNF biology, pathogenic mechanisms and emerging therapeutic strategiesInflammation in Sickle Cell Disease: Differential and Down-Expressed Plasma Levels of Annexin A1 ProteinA Rationally Designed TNF-α Epitope-Scaffold Immunogen Induces Sustained Antibody Response and Alleviates Collagen-Induced Arthritis in MiceIs secukinumab a safe alternative treatment for ankylosing spondylitis with Guillain Barré syndrome after anti-TNF-α treatment? Case report and literature review.Phosphorylation of iRhom2 at the plasma membrane controls mammalian TACE-dependent inflammatory and growth factor signalling.Blimp-1-Dependent IL-10 Production by Tr1 Cells Regulates TNF-Mediated Tissue Pathology.Effects of Antitumor Necrosis Factor Therapy on Osteoprotegerin, Neopterin, and sRANKL Concentrations in Patients with Rheumatoid Arthritis.Progranulin inhibits expression and release of chemokines CXCL9 and CXCL10 in a TNFR1 dependent mannerThe TNF Receptor Superfamily in Co-stimulating and Co-inhibitory ResponsesEstablishment and evaluation of a transgenic mouse model of arthritis induced by overexpressing human tumor necrosis factor alpha.Absence of TNF-α enhances inflammatory response in the newborn lung undergoing mechanical ventilation.Induction maintenance with tumour necrosis factor-inhibitor combination therapy with discontinuation versus methotrexate monotherapy in early rheumatoid arthritis: a systematic review and meta-analysis of efficacy in randomised controlled trials.Intraarticular overexpression of Smad7 ameliorates experimental arthritis.Macrophage Polarization and Bone Formation: A review.Drugs for Autoimmune Inflammatory Diseases: From Small Molecule Compounds to Anti-TNF Biologics.Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases.What rheumatologists need to know about innate lymphocytes.Functions of interleukin-34 and its emerging association with rheumatoid arthritis.Pro-inflammatory cytokines mediate GPCR dysfunction.Biosimilar biologic drugs: a new frontier in medical care.In Vivo PET Imaging of the Activated Immune Environment in a Small Animal Model of Inflammatory ArthritisMacrophage-derived tumor necrosis factor-α mediates diabetic renal injury.Reduced skin blistering in experimental epidermolysis bullosa acquisita after anti-TNF treatment.Intermittent Hypoxia Contributes to the Lung Damage by Increased Oxidative Stress, Inflammation, and Disbalance in Protease/Antiprotease System.Pharmacokinetic Effects of Antidrug Antibodies Occurring in Healthy Subjects After a Single Dose of Intravenous Infliximab.Chronic Inflammation Increases the Sensitivity of Mouse Treg for TNFR2 Costimulation.Novel, Anti-hTNF-α Variable New Antigen Receptor Formats with Enhanced Neutralizing Potency and Multifunctionality, Generated for Therapeutic Development.Model answers: Rational application of murine models in arthritis research.Critical role of TNF inhibition in combination therapy for elderly mice with atherosclerosis.Pyoderma gangrenosum and pyogenic arthritis presenting as severe sepsis in a rheumatoid arthritis patient treated with golimumab.LAIR-1 shedding from human fibroblast-like synoviocytes in rheumatoid arthritis following TNF-α stimulation.Assaying kinase activity of the TPL-2/NF-κB1 p105/ABIN-2 complex using an optimal peptide substrate.Influence of Adalimumab on the Expression Profile of Genes Associated with the Histaminergic System in the Skin Fibroblasts In Vitro.Sequencing and cloning of antigen-specific antibodies from mouse memory B cells.Interrelationships between Infliximab and Recombinant Tumor Necrosis Factor-α in Plasma Using Minimal Physiologically Based Pharmacokinetic Models.IL-17F regulates psoriasis-associated genes through IκBζ.Pro-resolving mediators promote resolution in a human skin model of UV-killed Escherichia coli-driven acute inflammation.TNF and granulocyte macrophage-colony stimulating factor interdependence mediates inflammation via CCL17.Amelioration of Experimental Autoimmune Arthritis Through Targeting of Synovial Fibroblasts by Intraarticular Delivery of MicroRNAs 140-3p and 140-5p.A New Venue of TNF Targeting.
P2860
Q26776492-ADD8BAE7-2D54-4083-8572-99658E1F4138Q28553088-533D5D8A-CAA8-43D1-89A2-5583C307CCD3Q28554288-59D50643-F9A0-4FC0-B3B9-C76F87704862Q31165527-DE65A0B2-B18A-45C7-A532-EDF6F1A38936Q33704501-DE1CAFCB-4948-4445-B68A-9988359CD1D0Q35893711-D575CFFF-B936-4815-AD8B-B9008EFD04F2Q36245404-43EEC694-DD60-4244-960B-F46EACBCA68BQ36595482-4093918E-CF1D-436D-8FCC-2F9C85AF3D99Q36940326-FBA73AB4-47F7-4F71-BD0F-6B2CB03812FFQ36961325-9B98B2DC-CF21-4E17-8AE7-E679411B07EBQ36976617-4BFBB0D8-0A8C-40AB-B839-DD87C3BBF6F8Q37236822-D448F1E0-FDC6-4BF3-A4BD-BD95F291A768Q37330465-52995827-9131-4EC9-A25E-6F9F4AB8755AQ38615856-7C7CB638-DA1A-4F25-BF59-30A147EC1CEAQ38645738-20A07FBE-849B-41B0-9EC8-466A339909DFQ38748557-7768DD37-CBDE-4E87-A76D-0BD75B73F8AFQ38809547-47D8A972-994E-4FC1-B20F-F501DA65F99FQ38934355-1A2CE56C-53A3-44D8-98A4-B9A8BAF6F004Q39070066-F1BFDCA1-1B79-4D74-B227-DAA386A563CDQ39200937-A577316C-08AF-43C4-A8BE-A815F5213181Q41068428-0D4FDBC2-123D-4973-B422-9D15A02205E9Q41559116-4B06B8CA-2A70-47E3-B0AE-034EE4DAE18BQ42320550-ABCAD7A2-538C-4927-9FC0-62313EFD4033Q46465518-D8381908-9F80-4ADA-AC74-DC0795B70A23Q47132165-67B7BC72-425E-41BE-A20F-227A893E97E4Q47219412-F5E4EF1B-C2FF-4A8C-AB35-76C99B832F11Q47221249-8CCDE3FA-11CD-436D-AEAD-B9554E6737B9Q47807913-DA520E36-232B-49A8-87B3-9F9A9D496AF9Q48038255-CD7A7707-A75B-4D25-B421-AFDCA7597221Q48118262-9758850F-256C-476E-9749-E2415B51CD32Q48254175-3F70287A-1402-4E98-99AE-C62C0F7C9456Q49920636-10985A84-363F-41A6-AF07-15CD1E1AF293Q50296996-3140794D-1911-4702-A93F-A5A0554E7158Q50623862-A3EB01D9-26FE-42A1-9B2F-3ECACF7B9540Q51057357-436487F9-B946-4FCB-AE01-BD2DEA4A1A0BQ51542359-18AE22ED-C52A-4E2A-9D2E-E6629DF98CCFQ51736941-BD78CD8A-DC0A-48A3-83AA-9A35BF023EEFQ52644010-E6F67679-9C14-41A9-BD97-09080A81E0A9Q53663246-70FA551B-EEEF-4390-BBA3-B1DFBE73728BQ55001725-F6F8DDA8-6602-4265-9F30-3161EE6ABC39
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Anti-TNF therapy: past, present and future
@ast
Anti-TNF therapy: past, present and future
@en
Anti-TNF therapy: past, present and future
@nl
type
label
Anti-TNF therapy: past, present and future
@ast
Anti-TNF therapy: past, present and future
@en
Anti-TNF therapy: past, present and future
@nl
prefLabel
Anti-TNF therapy: past, present and future
@ast
Anti-TNF therapy: past, present and future
@en
Anti-TNF therapy: past, present and future
@nl
P2860
P3181
P356
P1476
Anti-TNF therapy: past, present and future
@en
P2093
M. Feldmann
P2860
P3181
P356
10.1093/INTIMM/DXU102
P407
P577
2015-01-01T00:00:00Z